Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Pension: 2023-2024

Historic Pension for Monte Rosa Therapeutics (GLUE) over the last 2 years, with Dec 2024 value amounting to $3.7 million.

  • Monte Rosa Therapeutics' Pension rose 67.91% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 67.91%. This contributed to the annual value of $3.7 million for FY2024, which is 36.45% up from last year.
  • According to the latest figures from FY2024, Monte Rosa Therapeutics' Pension is $3.7 million, which was up 36.45% from $2.7 million recorded in FY2023.
  • In the past 5 years, Monte Rosa Therapeutics' Pension ranged from a high of $3.7 million in FY2024 and a low of $2.7 million during FY2023.
  • Moreover, its 2-year median value for Pension was $3.2 million (2023), whereas its average is $3.2 million.
  • Data for Monte Rosa Therapeutics' Pension shows a peak YoY spiked of 36.45% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Monte Rosa Therapeutics' Pension stood at $2.7 million in 2023, then soared by 36.45% to $3.7 million in 2024.